COMMUNIQUÉS West-GlobeNewswire

Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
10/03/2026
Deramiocel has the potential to become the first therapy to address both skeletal and cardiac manifestations of Duchenne muscular dystrophy BLA supported by positive pivotal HOPE-3 Phase 3 results, including achievement [...]
SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
10/03/2026
TEL AVIV, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage pharmaceutical company [...]
Baylor Genetics Enhances Whole Genome Sequencing Test with Optical Genome Mapping and Long‑Read Sequencing as Supplemental Technologies
10/03/2026
New technologies enable enhanced short tandem repeat analysis, complex structural variant analysis, and methylation analysis of FMR1 HOUSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Baylor Genetics , a leading diagnostic [...]
GLP Diet Review: A Personalized App Designed to Support GLP-1 Weight Loss Journeys
10/03/2026
NEW YORK, March 10, 2026 (GLOBE NEWSWIRE) -- GLP Diet introduces a personalized wellness app designed to support individuals using GLP-1 weight-loss medications. The app combines structured nutrition guidance, light [...]
Shoreline Recovery Center Experts Announce New Therapeutic Approach In Addiction Recovery
10/03/2026
Shoreline Recovery Center experts warn rebuilding family relationship with loved ones is crucial in recovery SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- The disease of addiction has a domino effect – deeply impacting [...]
Experts at Park Mental Health Announce New Therapeutic Approach: Highlighting the Role of Community Support in Recovery
10/03/2026
Park Mental Health highlights the importance of supportive relationships in mental health journey SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- It can be a difficult task to support an individual struggling with mental [...]
Validic Announces Integration with Salesforce Health Cloud to Advance Connected Care and Value-Based Engagement
10/03/2026
New integration unifies remote patient monitoring and wearable data within Salesforce Health Cloud to enable proactive care management across health systems, life sciences, and payers LAS VEGAS, March 10, 2026 (GLOBE [...]
Smith+Nephew launches next-generation ALLEVYN™ COMPLETE CARE Foam Dressing - designed for high performance in wound management and pressure injury prevention
10/03/2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, recently announced the launch of ALLEVYN ♢ COMPLETE CARE Foam Dressing, featuring proprietary technologies and performance backed by a portfolio of [...]
Coloplast A/S - Allocation of Share Options
10/03/2026
Report on transactions of executives and related parties in Coloplast shares and related securities According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives [...]
PolTREG moves forward with the European registration process for TREG therapy in type 1 diabetes
10/03/2026
The European Medicines Agency (EMA) has officially qualified PolTREG to submit an application for marketing authorization in the European Union for the PolTREG-T1D cell preparation. GDAŃSK, Poland, March 10, 2026 (GLOBE [...]
Kymera Therapeutics Announces Late-Breaking Oral Presentation of KT-621 Phase 1b Data at the American Academy of Dermatology (AAD) Annual Meeting
10/03/2026
WATERTOWN, Mass., March 10, 2026 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform
10/03/2026
- Clinical trial results support progression of CGM+ toward regulatory submissions and scaled commercialization - Anticipating initiation of pivotal clinical trial in 2026 - Updated electronics architecture delivers [...]
Polyrizon Announces GMP Manufacturing of Clinical Trial Material (CTM) with Eurofins CDMO AmatsiAquitaine S.A.S for Planned U.S. Clinical Study
10/03/2026
Raanana, Israel, March 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a pre-clinical-stage biotechnology company developing intranasal administrated solutions, today announced [...]
Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026
10/03/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES 10 MARCH 2026 at 13.50 EET Orion Corporation: Transfer of 172,778 own B shares on 10 March 2026 In accordance with a decision by the Board of [...]
Trinity Biotech Provides Business and Trading Update
10/03/2026
DUBLIN, March 10, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, [...]
SAB BIO Announces Additional Phase 1 Data for SAB-142 in Adult Patients with Established Autoimmune Type 1 Diabetes
10/03/2026
Results demonstrated early signals of C-peptide preservation T1D key opinion leader, Michael J. Haller, MD, provided a recorded webinar reviewing the SAB-142 Phase 1 data MIAMI, March 10, 2026 (GLOBE NEWSWIRE) -- SAB [...]
EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference
10/03/2026
EDAP to Present at Oppenheimer 36 th Annual Healthcare MedTech & Services Conference Company to Present and Host 1x1 Investor Meetings on Wednesday, March 18 th , 2026 AUSTIN, Texas, March 10, 2026 -- EDAP TMS SA ( [...]
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
10/03/2026
GARDEN CITY, N.Y., March 10, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Piston Bio Announces FDA Alignment on PST-101 Development Program for Cancer-Related Apathy
10/03/2026
MORRISTOWN, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Piston Bio LLC, a clinical-stage biotechnology company developing therapeutics targeting neuroimmune mechanisms in cancer, today announced the completion of a Type B [...]

Pages